Based on TCGA and GTEx databases, the expression levels of FOS, GADD45B, and EGR1 in liver hepatocellular carcinoma (LIHC) and lung adenocarcinoma (LUAD) were lower than those in normal samples. This evidence concerns the gene FOS and lung adenocarcinoma.